6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine
C137H97BrF25N31O — CID 158730247
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine
6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine (PubChem CID 158730247) has the molecular formula C137H97BrF25N31O and a molecular weight of 2748.35 g/mol. Its IUPAC name is 6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine.
Molecular Properties
| Compound Name | 6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine |
|---|---|
| PubChem CID | 158730247 |
| Molecular Formula | C137H97BrF25N31O |
| Molecular Weight | 2748.35 g/mol |
| Exact Mass | 2745.73 |
| IUPAC Name | 6-(3-bromo-4-fluorophenyl)-3-(4-fluoro-1H-indol-5-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyrazine;6-(3-cyclopropyl-4-fluorophenyl)-2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(4-fluoro-3-propan-2-ylphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(3-propan-2-yloxyphenyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-(2-propan-2-yl-4-pyridinyl)imidazo[1,2-a]pyrazine;2-(1,1-difluoroethyl)-3-(4-fluoro-1H-indazol-5-yl)-6-[2-(trifluoromethyl)-4-pyridinyl]imidazo[1,2-a]pyrazine |
| SMILES | CC(C)Oc1cccc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C(C)(F)F)nc3cn2)c1.CC(C)c1cc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C(C)(F)F)nc3cn2)ccc1F.CC(C)c1cc(-c2cn3c(-c4ccc5[nH]ncc5c4F)c(C(C)(F)F)nc3cn2)ccn1.CC(F)(F)c1nc2cnc(-c3ccc(F)c(C4CC4)c3)cn2c1-c1ccc2[nH]ncc2c1F.CC(F)(F)c1nc2cnc(-c3ccnc(C(F)(F)F)c3)cn2c1-c1ccc2[nH]ncc2c1F.Fc1ccc(-c2cn3c(-c4ccc5[nH]ccc5c4F)c(C(F)(F)F)nc3cn2)cc1Br |
| InChI | InChI=1S/C24H17F4N5.C24H19F4N5.C24H20F3N5O.C23H19F3N6.C21H10BrF5N4.C21H12F6N6/c1-24(27,28)23-22(14-5-7-18-16(21(14)26)9-30-32-18)33-11-19(29-10-20(33)31-23)13-4-6-17(25)15(8-13)12-2-3-12;1-12(2)15-8-13(4-6-17(15)25)19-11-33-20(10-29-19)31-23(24(3,27)28)22(33)14-5-7-18-16(21(14)26)9-30-32-18;1-13(2)33-15-6-4-5-14(9-15)19-12-32-20(11-28-19)30-23(24(3,26)27)22(32)16-7-8-18-17(21(16)25)10-29-31-18;1-12(2)17-8-13(6-7-27-17)18-11-32-19(10-28-18)30-22(23(3,25)26)21(32)14-4-5-16-15(20(14)24)9-29-31-16;22-13-7-10(1-3-14(13)23)16-9-31-17(8-29-16)30-20(21(25,26)27)19(31)12-2-4-15-11(18(12)24)5-6-28-15;1-20(23,24)19-18(11-2-3-13-12(17(11)22)7-30-32-13)33-9-14(29-8-16(33)31-19)10-4-5-28-15(6-10)21(25,26)27/h4-12H,2-3H2,1H3,(H,30,32);4-12H,1-3H3,(H,30,32);4-13H,1-3H3,(H,29,31);4-12H,1-3H3,(H,29,31);1-9,28H;2-9H,1H3,(H,30,32) |
| InChIKey | IKZSNSBWJLRRJF-UHFFFAOYSA-N |
| XLogP | 36.55 |
| TPSA | 375.34 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 195 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2748.35 |
| LogP ≤ 5 | 36.55 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 26 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158730247 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.